Palisade Bio, Inc.
PALI
$1.66
-$0.18-9.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 30.82% | -14.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.78% | 23.07% | |||
| Operating Income | -2.78% | -23.07% | |||
| Income Before Tax | -3.02% | -24.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.02% | -24.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.02% | -24.84% | |||
| EBIT | -2.78% | -23.07% | |||
| EBITDA | -2.78% | -23.08% | |||
| EPS Basic | 33.88% | -24.80% | |||
| Normalized Basic EPS | 33.88% | -24.81% | |||
| EPS Diluted | 33.88% | -24.80% | |||
| Normalized Diluted EPS | 33.88% | -24.81% | |||
| Average Basic Shares Outstanding | 55.80% | 0.03% | |||
| Average Diluted Shares Outstanding | 55.80% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||